Stay updated on Nivolumab in Hodgkin's Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin's Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Site-wide fund­ing-delay notice was added at the top, and the release version updated to Revision: v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T10:29:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Show glossary feature and updated footer metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T06:25:56.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:35:43.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page's Locations section was updated to include additional sites across the US, Canada, and the UK. The revision note shows version 3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:21:19.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Publications section now states that items are automatically filled from PubMed and may not be about the study. A revision tag was updated to Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:08.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    - Removed the lapse in government funding notice banner from the page. The banner previously warned that information may not be up to date due to funding issues.
    Difference
    0.3%
    Check dated 2025-11-18T07:10:30.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin's Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.